MétaCan
Menu
← Retour à la cohorte
Enregistrement W4230590552 · doi:10.1097/ju.0000000000001071.03

Reply by Authors

2020· letter· en· W4230590552 sur OpenAlexaboutno aff
Nima Almassi, Emily Vertosick, Chun Huang, Nathan C. Wong, Shawn Dason, Victor McPherson, Lucas Dean, Nicole Benfante, Daniel D. Sjoberg, Jonathan E. Rosenberg, Dean F. Bajorin, Harry W. Herr, Guido Dalbagni, Bernard H. Bochner

Notice bibliographique

RevueThe Journal of Urology · 2020
Typeletter
Langueen
DomaineMedicine
ThématiqueBladder and Urothelial Cancer Treatments
Établissements canadiensnon disponible
Organismes subventionnairesnon disponible
Mots-clésMedicine

Résumé

récupéré en direct d'OpenAlex

No AccessJournal of UrologyAdult Urology1 Oct 2020Reply by Authorsis a reply to letterEditorial CommentEditorial Comment Nima Almassi, Eugene K. Cha, Emily A. Vertosick, Chun Huang, Nathan Wong, Shawn Dason, Victor McPherson, Lucas Dean, Nicole Benfante, Daniel D. Sjoberg, Jonathan E. Rosenberg, Dean F. Bajorin, Harry W. Herr, Guido Dalbagni, and Bernard H. Bochner Nima AlmassiNima Almassi Urology Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, New York Recipient of National Institutes of Health T32 Ruth L. Kirschstein Institutional National Research Service Award. Equal study contribution. More articles by this author , Eugene K. ChaEugene K. Cha Urology Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, New York Equal study contribution. More articles by this author , Emily A. VertosickEmily A. Vertosick Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, New York More articles by this author , Chun HuangChun Huang Urology Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, New York More articles by this author , Nathan WongNathan Wong Urology Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, New York More articles by this author , Shawn DasonShawn Dason Urology Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, New York Current affiliation: Department of Urology, Ohio State University Comprehensive Cancer Center, Columbus, Ohio. More articles by this author , Victor McPhersonVictor McPherson Urology Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, New York Current affiliation: Division of Urology, McGill University, Montreal, Quebec, Canada. More articles by this author , Lucas DeanLucas Dean Urology Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, New York Current affiliation: Division of Urology, University of Alberta Faculty of Medicine & Dentistry, Edmonton, Alberta, Canada. More articles by this author , Nicole BenfanteNicole Benfante Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, New York More articles by this author , Daniel D. SjobergDaniel D. Sjoberg Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, New York More articles by this author , Jonathan E. RosenbergJonathan E. Rosenberg Genitourinary Oncology Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York Financial interest and/or other relationship with Merck, Illumina, UpToDate, Bristol-Myers Squibb, AstraZeneca, Medscape, Vindico, Peerview, Chugai Pharma, Lilly, Agensys, Roche/Genentech, Sanofi, AstraZeneca/MedImmune, EMD Serono, Seattle Genetics, Bayer, Inovio Pharmaceuticals, BioClin Therapeutics, QED Therapeutic, Adicet Bio, Sensei Biotherapeutics, Genentech, Oncogenex, Mirati Therapeutics, Novartis, Viralytics and Incyte. More articles by this author , Dean F. BajorinDean F. Bajorin Genitourinary Oncology Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York Financial interest and/or other relationship with Merck, Pfizer, Bristol-Myers Squibb, Urogen, Genentech and Eli Lilly. More articles by this author , Harry W. HerrHarry W. Herr Urology Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, New York More articles by this author , Guido DalbagniGuido Dalbagni Urology Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, New York More articles by this author , and Bernard H. BochnerBernard H. Bochner ††Correspondence: Urology Service, Department of Surgery, Kimmel Center for Prostate and Urologic Cancers, Memorial Sloan Kettering Cancer Center, 353 East 68th St., New York, New York 10065 telephone: 646-422-4387; FAX: 212-988-0759; E-mail Address: [email protected] Urology Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, New York Financial interest and/or other relationship with Olympus. More articles by this author View All Author Informationhttps://doi.org/10.1097/JU.0000000000001071.03AboutFull TextPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissionsReprints ShareFacebookLinked InTwitterEmail "Reply by Authors." The Journal of Urology, 204(4), p. 684 © 2020 by American Urological Association Education and Research, Inc.FiguresReferencesRelatedDetailsRelated articlesJournal of Urology23 Jul 2020Editorial CommentJournal of Urology23 Jul 2020Editorial Comment Volume 204Issue 4October 2020Page: 684-684 Advertisement Copyright & Permissions© 2020 by American Urological Association Education and Research, Inc.MetricsAuthor Information Nima Almassi Urology Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, New York Recipient of National Institutes of Health T32 Ruth L. Kirschstein Institutional National Research Service Award. Equal study contribution. More articles by this author Eugene K. Cha Urology Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, New York Equal study contribution. More articles by this author Emily A. Vertosick Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, New York More articles by this author Chun Huang Urology Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, New York More articles by this author Nathan Wong Urology Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, New York More articles by this author Shawn Dason Urology Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, New York Current affiliation: Department of Urology, Ohio State University Comprehensive Cancer Center, Columbus, Ohio. More articles by this author Victor McPherson Urology Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, New York Current affiliation: Division of Urology, McGill University, Montreal, Quebec, Canada. More articles by this author Lucas Dean Urology Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, New York Current affiliation: Division of Urology, University of Alberta Faculty of Medicine & Dentistry, Edmonton, Alberta, Canada. More articles by this author Nicole Benfante Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, New York More articles by this author Daniel D. Sjoberg Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, New York More articles by this author Jonathan E. Rosenberg Genitourinary Oncology Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York Financial interest and/or other relationship with Merck, Illumina, UpToDate, Bristol-Myers Squibb, AstraZeneca, Medscape, Vindico, Peerview, Chugai Pharma, Lilly, Agensys, Roche/Genentech, Sanofi, AstraZeneca/MedImmune, EMD Serono, Seattle Genetics, Bayer, Inovio Pharmaceuticals, BioClin Therapeutics, QED Therapeutic, Adicet Bio, Sensei Biotherapeutics, Genentech, Oncogenex, Mirati Therapeutics, Novartis, Viralytics and Incyte. More articles by this author Dean F. Bajorin Genitourinary Oncology Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York Financial interest and/or other relationship with Merck, Pfizer, Bristol-Myers Squibb, Urogen, Genentech and Eli Lilly. More articles by this author Harry W. Herr Urology Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, New York More articles by this author Guido Dalbagni Urology Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, New York More articles by this author Bernard H. Bochner Urology Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, New York ††Correspondence: Urology Service, Department of Surgery, Kimmel Center for Prostate and Urologic Cancers, Memorial Sloan Kettering Cancer Center, 353 East 68th St., New York, New York 10065 telephone: 646-422-4387; FAX: 212-988-0759; E-mail Address: [email protected] Financial interest and/or other relationship with Olympus. More articles by this author Expand All Advertisement PDF downloadLoading ...

Récupéré en direct depuis OpenAlex et désinversé. Les résumés ne sont pas conservés dans cette base de données : les index inversés représentent 8,6 Go des 9,3 Go de texte de la base, et le serveur dispose de 13 Go libres.

Comment cette classification a été obtenuedéplier

Prédiction machine sur la base complète

Imitation des enseignants

Ni prévalence calibrée, ni vérité terrain. Validation humaine à venir. Le volet Gemma est une étiquette directe du modèle pour chaque travail de la base, lue sur la notice réduite au titre. Le volet Codex est un classifieur appris des 10 348 étiquettes directes de Codex et calibré sur les taux pondérés de l'échantillon; les champs sans appui suffisant ne portent aucun appel Codex. Le mode candidate est l'union des deux volets; le consensus est leur intersection. Ces sorties portent le statut machine_predicted_unvalidated et ne sont pas des étiquettes humaines.

score de la tête « metaresearch » (Codex)0,004
score de la tête « metaresearch » (Gemma)0,055
Version: metacan-v3-hybrid-931329e0061cStatut de validation: machine_predicted_unvalidated
Catégories candidatesaucune
Catégories consensuellesaucune
DomaineSignal candidat: aucune · Signal consensuel: aucune
Devis d'étudeSignal candidat: Sans objet · Signal consensuel: Sans objet
GenreSignal candidat: Éditorial · Signal consensuel: aucune
Score de désaccord entre enseignants0,100
Score d'incertitude au seuil0,336

Scores du classifieur distillé par catégorie (deux têtes)

CatégorieCodexGemma
Métarecherche0,0040,055
Méta-épidémiologie (sens strict)0,0010,001
Méta-épidémiologie (sens large)0,0010,002
Bibliométrie0,0010,001
Études des sciences et des technologies0,0030,002
Communication savante0,0050,005
Science ouverte0,0020,003
Intégrité de la recherche0,0190,020
Charge utile insuffisante (le modèle a refusé de juger)0,1000,083

Scores machine (provisoires)

Les deux têtes enseignantes du modèle étudiant, lues sur ce travail. Un score ordonne la base pour la relecture; il n'affirme jamais une catégorie, et le statut de validation accompagne chaque rangée tel quel.

Scores de référence d'un modèle non mature (critères de maturité non atteints, 7 itérations). Un score ordonne; il n'affirme jamais une catégorie.

Tête enseignante Opus0,022
Tête enseignante GPT0,280
Écart entre enseignants0,258 · la distance entre les deux têtes enseignantes sur ce seul travail
Statut de validationscore_only:v0-immature-baseline · tel quel depuis la passe de notation : score_only signifie que le nombre peut ordonner les travaux, et qu'aucune étiquette de catégorie n'en découle

Classification

machine, non validée

Prédiction automatique; un appel candidat d’une seule source (Gemma direct ou Codex distillé), pas un consensus.

Les modèles n’ont appliqué aucune catégorie : rien dans la taxonomie ne correspondait à ce travail.
Devis d'étudeSans objet
Domainenon disponible
GenreÉditorial

Le détail, modèle par modèle et score par score, se trouve en fin de page sous « Comment cette classification a été obtenue ».

En bref

Citations0
Publié2020
Routes d'admission1
Résumé présentoui

Explorer davantage

Même revueThe Journal of Urology→Même sujetBladder and Urothelial Cancer Treatments→Travaux en français237 207→